Skip to content
DraconiticResearch
Search Sources API
181,713 studies31 sourcesUpdated 47 min ago
Peer-reviewedCC BY 4.0Frontiers in Immunology

HIFU-driven remodeling of fibrotic perivascular myeloid niches in hepatocellular carcinoma: implications for PD-1/PD-L1 blockade

  • Zhen Wei1
  • Yao Liao2,3
  1. 1Department of Medical Equipment, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China
  2. 2Sichuan Clinical Research Center for Radiation and Therapy, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China
  3. 3Department of Oncology, Mianyang Central Hospital,School of Medicine, University of Electronic Science and Technology of China
Open at sourcePDFDOICite

Abstract

Hepatocellular carcinoma (HCC) usually develops within chronically inflamed and fibrotic liver tissue. This background creates an organ-specific immune niche in which macrophages, sinusoidal endothelial cells, activated stellate cells and extracellular matrix constrain T-cell access and sustain checkpoint-dependent tolerance. Spatial mapping places VEGFA-positive macrophages near CD34-positive endothelium and predicts VEGFA signaling, defining a candidate vascular barrier to PD-1/PD-L1 blockade. High-intensity focused ultrasound (HIFU) can disrupt tumor tissue and may alter this niche. Mechanical HIFU can fragment tumor tissue, release immunogenic material and activate dendritic cells, while focused ultrasound approaches can repolarize macrophages, increase T-cell infiltration and induce adaptive PD-L1 expression. These preclinical effects motivate combination with checkpoint inhibition, while direct niche remodeling in fibrotic HCC remains to be tested. This mini review examines how HIFU may remodel the fibrotic perivascular myeloid niche, why the resulting inflammatory window may sensitize HCC to PD-1/PD-L1 blockade, and which spatial and temporal biomarkers are required for clinical translation.

Related

  1. Intercepting hepatocellular carcinoma in chronic hepatitis B: a structured critical review of Chinese herbal medicine and the immune–fibrotic evidence
    Jingjing Yang, Lihui Liu, Yingjie Liu +6
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyFrontiersCrossref
  2. Liver-resident cellular determinants of oncolytic virotherapy in hepatocellular carcinoma: viral susceptibility and spatial immune remodeling.
    Ding Hu, Qiong Wang
    Frontiers in cell and developmental biologyPeer-reviewedCC BYFull textGenetics & genomicsEurope PMC
  3. Matrix‑stiffness‑triggered mechanotransduction fuels hepatocellular carcinoma proliferation through Hippo‑orchestrated ANKRD1‑PRMT5 complex‑driven arginine methylome remodeling
    Jia-Cheng Huang, Bao-Dong Chen, Yuan Xu +12
    Military Medical ResearchPeer-reviewedCC BY 4.0Full textCell biologyPMC
  4. Fibrotic Remodeling in Retinal Vascular Diseases: Cellular Origins, Molecular Mechanisms, and Therapeutic Perspectives.
    Jia Yu Ning, Brian Wang, Miyuki Ishida Yamamoto +1
    CellsPeer-reviewedCC BYFull textCell biologyEurope PMC
  5. Sustained YAP/TAZ activation promotes aberrant alveolar epithelial cell differentiation and drives persistent fibrotic remodeling
    Isabella P. Gaona, A. Scott McCall, Natalie M. Geis +13
    JCI InsightPeer-reviewedCC BY8 citedCell biologyOpenAlex

Cite

BibTeXRIS
BibTeX
@article{wei2026hifudriven,
  title = {{HIFU-driven remodeling of fibrotic perivascular myeloid niches in hepatocellular carcinoma: implications for PD-1/PD-L1 blockade}},
  author = {Zhen Wei and Yao Liao},
  journal = {Frontiers in Immunology},
  year = {2026},
  month = oct,
  doi = {10.3389/fimmu.2026.2018159},
  url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.2018159/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - HIFU-driven remodeling of fibrotic perivascular myeloid niches in hepatocellular carcinoma: implications for PD-1/PD-L1 blockade
AU  - Zhen Wei
AU  - Yao Liao
PY  - 2026
DA  - 2026/10/26
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.2018159
UR  - https://www.frontiersin.org/articles/10.3389/fimmu.2026.2018159/full
AB  - Hepatocellular carcinoma (HCC) usually develops within chronically inflamed and fibrotic liver tissue. This background creates an organ-specific immune niche in which macrophages, sinusoidal endothelial cells, activated stellate cells and extracellular matrix constrain T-cell access and sustain checkpoint-dependent tolerance. Spatial mapping places VEGFA-positive macrophages near CD34-positive endothelium and predicts VEGFA signaling, defining a candidate vascular barrier to PD-1/PD-L1 blockade. High-intensity focused ultrasound (HIFU) can disrupt tumor tissue and may alter this niche. Mechanical HIFU can fragment tumor tissue, release immunogenic material and activate dendritic cells, while focused ultrasound approaches can repolarize macrophages, increase T-cell infiltration and induce adaptive PD-L1 expression. These preclinical effects motivate combination with checkpoint inhibition, while direct niche remodeling in fibrotic HCC remains to be tested. This mini review examines how HIFU may remodel the fibrotic perivascular myeloid niche, why the resulting inflammatory window may sensitize HCC to PD-1/PD-L1 blockade, and which spatial and temporal biomarkers are required for clinical translation.
SN  - 1664-3224
ER  -